BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 38844902)

  • 1. Serum beta2-microglobulin acts as a biomarker for severity and prognosis in glioma patients: a preliminary clinical study.
    Liu ZY; Tang F; Wang J; Yang JZ; Chen X; Wang ZF; Li ZQ
    BMC Cancer; 2024 Jun; 24(1):692. PubMed ID: 38844902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of beta-2 microglobulin expression on the survival of glioma patients via modulating the tumor immune microenvironment.
    Tang F; Zhao YH; Zhang Q; Wei W; Tian SF; Li C; Yao J; Wang ZF; Li ZQ
    CNS Neurosci Ther; 2021 Aug; 27(8):951-962. PubMed ID: 33960680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum exosomal miR-301a as a potential diagnostic and prognostic biomarker for human glioma.
    Lan F; Qing Q; Pan Q; Hu M; Yu H; Yue X
    Cell Oncol (Dordr); 2018 Feb; 41(1):25-33. PubMed ID: 29076027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B2M overexpression correlates with malignancy and immune signatures in human gliomas.
    Zhang H; Cui B; Zhou Y; Wang X; Wu W; Wang Z; Dai Z; Cheng Q; Yang K
    Sci Rep; 2021 Mar; 11(1):5045. PubMed ID: 33658560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High levels of serum β2-microglobulin predict severity of coronary artery disease.
    You L; Xie R; Hu H; Gu G; Zheng H; Zhang J; Yang X; He X; Cui W
    BMC Cardiovasc Disord; 2017 Mar; 17(1):71. PubMed ID: 28249620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative neutrophil-lymphocyte ratio correlated with glioma grading and glioblastoma survival.
    Weng W; Chen X; Gong S; Guo L; Zhang X
    Neurol Res; 2018 Nov; 40(11):917-922. PubMed ID: 30074469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum beta-2 microglobulin as a prognostic biomarker in patients with mantle cell lymphoma.
    Yoo C; Yoon DH; Kim S; Huh J; Park CS; Park CJ; Lee SW; Suh C
    Hematol Oncol; 2016 Mar; 34(1):22-7. PubMed ID: 25689467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas.
    Lin Y; Jiang T; Zhou K; Xu L; Chen B; Li G; Qiu X; Jiang T; Zhang W; Song SW
    Neuro Oncol; 2009 Oct; 11(5):468-76. PubMed ID: 19164435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma miR-122 as a potential diagnostic and prognostic indicator in human glioma.
    Tang Y; Zhao S; Wang J; Li D; Ren Q; Tang Y
    Neurol Sci; 2017 Jun; 38(6):1087-1092. PubMed ID: 28367610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-dependent association of preoperative hematologic markers with glioma grade and progression.
    Xu W; Wang D; Zheng X; Ou Q; Huang L
    J Neurooncol; 2018 Apr; 137(2):279-287. PubMed ID: 29260361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum miR-100 is a potential biomarker for detection and outcome prediction of glioblastoma patients.
    Zhang H; Wang J; Wang Z; Ruan C; Wang L; Guo H
    Cancer Biomark; 2019; 24(1):43-49. PubMed ID: 30530966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of plasma miR-124 expression is a predictive biomarker for prognosis of glioma.
    Wang LQ; Sun W; Wang Y; Li D; Hu AM
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):271-276. PubMed ID: 30657585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas.
    Regazzo G; Terrenato I; Spagnuolo M; Carosi M; Cognetti G; Cicchillitti L; Sperati F; Villani V; Carapella C; Piaggio G; Pelosi A; Rizzo MG
    J Exp Clin Cancer Res; 2016 Jul; 35(1):124. PubMed ID: 27476114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrative Analysis of Neuregulin Family Members-Related Tumor Microenvironment for Predicting the Prognosis in Gliomas.
    Zhao WJ; Ou GY; Lin WW
    Front Immunol; 2021; 12():682415. PubMed ID: 34054873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative serum lactate dehydrogenase level predicts progression and prognosis in patients with glioma.
    Chen XY; Chen JY; Chen Y; Chen JF; Lin N; Ding CY; Kang DZ; Wang DL; Fang WH
    Clin Neurol Neurosurg; 2021 Oct; 209():106912. PubMed ID: 34509141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations among Serum Beta 2 Microglobulin, Malnutrition, Inflammation, and Advanced Cardiovascular Event in Patients with Chronic Kidney Disease.
    Wu HC; Lee LC; Wang WJ
    J Clin Lab Anal; 2017 May; 31(3):. PubMed ID: 27645611
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Qu S; Liu J; Wang H
    Front Immunol; 2021; 12():648416. PubMed ID: 33889156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic and prognostic value of serum vitronectin levels in human glioma.
    Chen MH; Lu C; Sun J; Chen XD; Dai JX; Cai JY; Chen XL
    J Neurol Sci; 2016 Dec; 371():54-59. PubMed ID: 27871448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma microRNA-720 may predict prognosis and diagnosis in glioma patients.
    Chen P; Zhang G; Zhou Q; Li Z
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32639004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.